Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Amy Sebastian-Deutsch, RN, DNP, CNS, APN, AOCNS

Advertisement

Articles by Amy Sebastian-Deutsch, RN, DNP, CNS, APN, AOCNS

Oncology Nurse Navigators and Community Health Workers: Building Unique Relationships for Cancer Care, Part II of II

ByAmy Sebastian-Deutsch, RN, DNP, CNS, APN, AOCNS
June 11th 2012

Amy Sebastian-Deutsch describes the potential for a collaborative relationship between Oncology Nurse Navigators and community health workers.

Advertisement

Latest Updated Articles

  • Oncology Nurse Navigators and Community Health Workers: Building Unique Relationships for Cancer Care, Part II of II
    Oncology Nurse Navigators and Community Health Workers: Building Unique Relationships for Cancer Care, Part II of II

    June 11th 2012



Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Approves Frontline Sevabertinib for HER2-Mutant Advanced NSCLC Patients

2

FDA Grants Final Approval to Cabozantinib Capsules Across Multiple Solid Tumor Indications

3

Advocacy and Self-Care: Emily Beard on Oncology Navigation

4

Frontline Sevabertinib Approved in HER2-Mutant NSCLC: Nursing Priorities

5

Personalizing Frontline ADC Selection in Metastatic Triple-Negative Breast Cancer

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us